Women’s Brain Project
Aim & scope
The purpose of the series is to provide comprehensive references on different topics in basic/clinical research being conducted on the influence of sex and gender in brain and mental health and precision medicine research. Titles cover sex and gender differences in basic and clinical neuroscience, explore the role of such differences in disease management and clinical trials, consider sex and gender biases in digital medicine, and delve into how artificial intelligence could leverage sex differences for precision medicine.
The Women’s Brain Project (WBP) is an international non-profit organization advocating for women’s brain and mental health. Founded in 2016, the WBP is a group of scientists hailing from various disciplines including medicine, neuroscience, psychology, pharmacology and communication who work together with caregivers, patients and their relatives, policymakers and other stakeholders. The WBP aims to stimulate a global discussion on gender and sex determinants of female vulnerability to brain and mental disease.
They propose a new, personalized way to develop and perform medical treatments, caregiving and prevention strategies together with novel technologies development, based on consideration of sex and gender differences. By promoting a scientific discussion on the specific vulnerability of the female brain to particular mental and brain diseases, WBP advocates for the development of sex- specific measures to foster mental health. They address these issues through publishing and promoting scientific research, debate, public engagement and advocacy. They host biennial scientific forums that foster an interdisciplinary discussion with patients, caregivers, regulators, policymakers, industry, artificial intelligence experts and academic scientists on the role of sex and gender in the management and treatment of brain and mental diseases.
Clinical and basic researchers, clinicians and advanced medical students in the fields of neurodegeneration, neuroscience, neurology, neuropsychology and neuropharmacology, biomedicine, and healthcare.
Audience
Clinical and basic researchers, clinicians and advanced medical students in the fields of neurodegeneration, neuroscience, neurology, neuropsychology and neuropharmacology, biomedicine, and healthcare.
Publish a book with Elsevier
Editor
MTF
Maria Teresa Ferretti
Chief Scientific Officer
Group Leader, Institute of Regenerative Medicine
Read more about Maria Teresa FerrettiASD
Annemarie Schumacher Dimech
Program Manager
CAS Comprehensive Palliative Care, University of Lucerne, Switzerland
Read more about Annemarie Schumacher DimechACS